Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 8 | |
Outperform | 10 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 15 analysts offering 12 month price targets for Xenon Pharmaceuticals Inc have a median target of 56.50, with a high estimate of 65.00 and a low estimate of 49.00. The median estimate represents a 30.21% increase from the last price of 43.39.
High | 49.8% | 65.00 |
Med | 30.2% | 56.50 |
Low | 12.9% | 49.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -3.38% |
Average growth rate | -30.01% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | +44.88% |
More ▼